Mixtard 30 Flexpen (3ml Each)
Marketer
Novo Nordisk India Pvt Ltd
Salt Composition
Insulin Isophane (70%) + Human insulin (30%)
Overview Mixtard 30 Flexpen (3ml Each)
NovoMix 30 FlexPen (3ml vials) combines fast- and intermediate-acting insulins to manage blood glucose in adult and pediatric patients with type 1 and type 2 diabetes. This insulin helps regulate blood sugar levels and is often used alongside other diabetes medications. Administered subcutaneously, your healthcare provider will instruct you on proper injection technique. Ideally, inject 15 minutes before or within 20 minutes after mealtimes. Discontinue use only under your doctor's guidance. This medication is part of a comprehensive treatment plan encompassing diet, exercise, and weight management as directed by your physician. Regular blood glucose monitoring is crucial for dose adjustment; track your results and share them with your doctor. Hypoglycemia (low blood sugar) is a common side effect; proper dosing, consistent meals, and regular blood sugar checks mitigate this risk. Excessive alcohol intake can also lower blood sugar. Injection site reactions (redness, swelling) may occur. Weight gain is possible. Other potential side effects include rash, edema, and itching. Avoid using this medication if you have hypoglycemia. Inform your doctor of any pre-existing kidney, liver, or heart conditions before starting treatment. Pregnant or breastfeeding individuals should consult their doctor for dosage adjustments.
Uses of Mixtard 30 Flexpen (3ml Each)
Managing Diabetes
Major Benefits of Mixtard 30 Flexpen (3ml Each):
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Mixtard 30 Flexpen (3ml Each):
- Hypoglycemia (low blood glucose level)
- Injection site reactions (pain, swelling, redness)
- Weight gain
How to use Mixtard 30 Flexpen (3ml Each):
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Mixtard 30 Flexpen (3ml Each) works:
Isophane insulin provides extended blood sugar regulation, whereas rapid-acting human insulin offers immediate effects. Their combined use achieves stable glucose management through enhanced glucose uptake in adipose and muscle tissues and reduced hepatic glucose output.
SAFETY ADVICE
AlcoholUNSAFE
Combining Mixtard 30 Flexpen (3ml vials) with alcohol is unsafe.
PregnancySAFE IF PRESCRIBED
The use of Mixtard 30 Flexpen (3ml vials) during pregnancy is usually deemed safe. Preclinical trials in animals have revealed minimal or no harmful consequences for the fetus; however, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Using Mixtard 30 Flexpen (3ml vials) while breastfeeding presents minimal risk. Research in humans indicates negligible transfer of the medication into breast milk, posing no discernible harm to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar abnormalities.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Mixtard 30 Flexpen (3ml vials). Dosage modification of Mixtard 30 Flexpen (3ml vials) might be necessary. Physician consultation is advised. Routine blood glucose checks are recommended to guide dosage alterations.
LiverCAUTION
Individuals with hepatic impairment should use Mixtard 30 Flexpen (3ml vials) cautiously. Dosage modification of Mixtard 30 Flexpen (3ml vials) may be necessary; physician consultation is advised. Routine blood glucose monitoring is suggested to guide appropriate dosage.
What if you forget to take Mixtard 30 Flexpen (3ml Each) :
Should you forget a Mixtard 30 Flexpen (3ml) injection, elevated blood glucose (hyperglycemia) could result. Monitor your blood sugar and adjust your subsequent dose as needed.
Facts to Know About Mixtard 30 Flexpen (3ml Each)
Label | Value |
---|---|
Developing Habits | No. |
Treatment Category | Diabetes Management |